Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (4) reported the occurrence of at least one case of various thyroid disorders as adverse events
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis
Unlike its parent compound, PT-141 was refined specifically for its effects on sexual desire and arousal
Patients should check each drugs website or ask their doctor or pharmacist about current savings options
While both Ozempic and Wegovy are an injectable semaglutide, they differ in strength and application
In a 2019 study led by Neil Iyengar, MD, a BCRF-funded scientist at Emory University, patients with a normal body mass index (BMI) but a body fat composition exceeding 30 percent were at greater risk for breast cancer